MIRVASO

Drug Galderma Laboratories, L.P.
Total Payments
$597,304
Transactions
778
Doctors
160
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2021 $238.09 6 6
2018 $14,627 9 5
2017 $582,439 763 151

Payments by Nature

Nature of Payment Amount Transactions Share
Royalty or License $292,306 6 48.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $194,600 84 32.6%
Grant $48,978 3 8.2%
Travel and Lodging $43,453 203 7.3%
Food and Beverage $17,968 482 3.0%

Top Doctors Receiving Payments for MIRVASO — Page 7

Doctor Specialty Location Total Records
, MD Dermatology Hinsdale, IL $3.54 1
, MD MOHS-Micrographic Surgery Franklin Square, NY $3.53 1
, M.D Dermatology Boston, MA $3.48 1
Scott Zahner Hinsdale, IL $3.38 1
, MD Dermatology Tampa, FL $3.09 1
, MD Dermatology Maitland, FL $2.88 2
, MD Dermatology Peoria, AZ $2.54 1
, M.D Dermatology Lutherville, MD $2.49 1
, MD Dermatology Bridgewater, NJ $1.60 1
, M.D MOHS-Micrographic Surgery Gainesville, FL $1.31 1

About MIRVASO

MIRVASO is a drug associated with $597,304 in payments to 160 healthcare providers, recorded across 778 transactions in the CMS Open Payments database. The primary manufacturer is Galderma Laboratories, L.P..

Payment data is available from 2017 to 2021. In 2021, $238.09 was paid across 6 transactions to 6 doctors.

The most common payment nature for MIRVASO is "Royalty or License" ($292,306, 48.9% of total).